CVS Health Co. (NYSE:CVS) Shares Bought by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. raised its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 310.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,523,824 shares of the pharmacy operator's stock after purchasing an additional 2,666,029 shares during the quarter. Assenagon Asset Management S.A. owned about 0.28% of CVS Health worth $238,739,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. McIlrath & Eck LLC grew its stake in CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 174 shares during the last quarter. Coppell Advisory Solutions LLC lifted its stake in CVS Health by 17.3% during the 4th quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock valued at $56,000 after acquiring an additional 189 shares during the period. EagleClaw Capital Managment LLC increased its stake in shares of CVS Health by 3.4% in the fourth quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator's stock worth $275,000 after acquiring an additional 200 shares during the period. Manchester Capital Management LLC raised its holdings in shares of CVS Health by 4.8% during the fourth quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator's stock worth $200,000 after purchasing an additional 204 shares during the last quarter. Finally, Angeles Investment Advisors LLC lifted its position in CVS Health by 3.7% during the fourth quarter. Angeles Investment Advisors LLC now owns 5,706 shares of the pharmacy operator's stock valued at $256,000 after purchasing an additional 204 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CVS has been the subject of a number of analyst reports. Wall Street Zen upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Piper Sandler increased their price target on CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a research report on Friday, March 21st. Leerink Partners upgraded CVS Health from a "market perform" rating to an "outperform" rating and boosted their price objective for the company from $55.00 to $75.00 in a research report on Thursday, February 13th. Cowen reissued a "buy" rating on shares of CVS Health in a research note on Monday, May 5th. Finally, Wells Fargo & Company reaffirmed an "overweight" rating and set a $84.00 price objective (up from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Two analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $74.75.

Insider Activity

In related news, Director Guy P. Sansone acquired 1,570 shares of CVS Health stock in a transaction on Thursday, June 5th. The shares were bought at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the purchase, the director now directly owns 12,007 shares in the company, valued at $764,845.90. This trade represents a 15.04% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 1.22% of the company's stock.

CVS Health Price Performance

CVS Health stock traded up $0.18 during trading hours on Thursday, hitting $65.90. The stock had a trading volume of 2,288,601 shares, compared to its average volume of 10,989,850. The stock has a market capitalization of $83.36 billion, a price-to-earnings ratio of 18.01, a PEG ratio of 0.98 and a beta of 0.56. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $72.51. The stock's fifty day moving average is $65.11 and its two-hundred day moving average is $60.05.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. The business had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The company's revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.31 earnings per share. As a group, analysts predict that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.04%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health's payout ratio is currently 63.48%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.